AuraZyme is a wholly owned subsidiary of CryoLife, Inc. (NYSE: CRY) a medical technology company based in suburban Atlanta, Georgia. AuraZyme⢠Pharmaceuticals is a development stage company founded to develop and commercialize therapeutic drug formulations that increase efficacy of drug therapy, lower drug dosage requirements, reduce side effects, and improve outcomes. AuraZyme is building a portfolio of targeted AZ-CINN⢠drug conjugates and AZ-Enzymes⢠to address multiple medical needs, including cancer, infection, and dissolution of blood clo
